UNSPSC 51283105: Micafungin

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R10H71BSWG. European Medicines Agency schedules Micafungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16444MIG. Micafungin generally arises in the molecular formula C56H71N9O23S. The term MICAFUNGIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46.) Most nations schedule micafungin under HS 29419000 and SITC 54139.

UNSPSC 51283105 Micafungin is a Commodity code that nominally covers the antifungal pharmaceutical product micafungin; however, the recent state and local contract opportunities indexed under this code show little activity directly aligned with that scope. The two opportunities posted in the most recent window involve different pharmaceutical products entirely — one for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) procured through a consortial piggyback vehicle, and the other for Naloxone and drug deactivation systems procured as public health supplies. State and local health departments and counties appear to be the primary issuing bodies using pharmaceutical commodity codes in this tier, typically through competitive bidding (IFB) or piggyback arrangements leveraging established wholesale pharmacy contracts.

Activity under this code is geographically sparse and appears to reflect the indexed data rather than robust demand. Illinois Department of Public Health and Seminole County, Florida represent the two recent issuers, with the Illinois procurement (completed award to Chartwell Rx LLC for $2,999,999.11 over three years via MMCAP Infuse consortial piggyback, closed as of September 11, 2026) and the Seminole County IFB (1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, originally posted June 30, 2026 with a July 26, 2023 response deadline that appears to be a data error). The code shows minimal recent relevant activity; vendors pursuing pharmaceutical supply contracts with state and local entities should verify that opportunities are properly classified under this specific Commodity code rather than a higher-tier Family or Class code covering pharmaceutical products more broadly.